These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2733765)

  • 1. About radiotherapy--Part II. Side effects and staff protection.
    Lancaster J
    Nurs RSA; 1989 Mar; 4(3):41-3. PubMed ID: 2733765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B
    Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection.
    Valentin J;
    Ann ICRP; 2005; 35(1):1-110, iii-iv. PubMed ID: 16164984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies.
    Cuscela D; Coffin D; Lupton GP; Cook JA; Krishna MC; Bonner RF; Mitchell JB
    Cancer J Sci Am; 1996; 2(5):273-8. PubMed ID: 9166544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
    Altmann S; Hoffmanns H
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Restriction of indications and first results with the high-dose rate-afterloading technic (iridium-192)].
    Kucera H; Weghaupt K
    Strahlentherapie; 1984 Aug; 160(8):469-73. PubMed ID: 6474520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.
    Metz JM; Smith D; Mick R; Lustig R; Mitchell J; Cherakuri M; Glatstein E; Hahn SM
    Clin Cancer Res; 2004 Oct; 10(19):6411-7. PubMed ID: 15475427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxicity of curative radiotherapy in elderly patients.
    Huguenin P; Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1996 Dec; 172(12):658-63. PubMed ID: 8972750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of post-operative abdomino-pelvic radiotherapy in intermediate- and high-risk epithelial ovarian carcinoma.
    Mosalaei A; Kazerooni T
    Eur J Cancer Care (Engl); 2008 Jul; 17(4):371-6. PubMed ID: 18537815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interstitial radiotherapy].
    Hammer J
    Wien Med Wochenschr; 1983 Jun; 133(12):307-9. PubMed ID: 6684364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postoperative irradiation of carcinoma of the corpus uteri using the iridium afterloading technic].
    Kucera H; Weghaupt K
    Strahlenther Onkol; 1988 Sep; 164(9):501-7. PubMed ID: 3175848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute gastrointestinal side effects of radiotherapy. What is certain in the treatment?].
    Paulsen F; Hoffmann W; Kortmann RD; Porschen R; Bamberg M
    Strahlenther Onkol; 1996 Feb; 172(2):53-63. PubMed ID: 8669046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of oral recombinant human granulocyte macrophage-colony stimulating factor in radiotherapy-induced esophagitis.
    Koc M; Onuk MD; Koruk M; Memik F
    Hepatogastroenterology; 2003; 50(53):1297-300. PubMed ID: 14571722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection for nurses during radiotherapy.
    Plane JH; Richardson MA; Herring A
    Prof Nurse; 1999 Dec; 15(3):168-71. PubMed ID: 10765325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying patient symptoms after radiotherapy using a nurse-managed telephone interview.
    Rose MA; Shrader-Bogen CL; Korlath G; Priem J; Larson LR
    Oncol Nurs Forum; 1996; 23(1):99-102. PubMed ID: 8628716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.